However, statins are known to impact inflammation26 and diabetes risk3: we found that female SLCO1B1*5 homozygotes (but not male) treated with atorvastatin or simvastatin at baseline assessment had higher CRP, ALT and HbA1c, further emphasising the increased importance of appropriate prescribing in females. This evidence concerns the gene CRP and diabetes mellitus.